AIFM2 and cancer: This report demonstrated that activation of the ACSL1/FSP1 cellular anti-ferroptosis pathway mentioned above after carboplatin treatment reduces the sensitivity of cancer cells to platinum chemotherapy and promotes cell survival (Fig. 6).